Filana Therapeutics
FLNA
103 hedge funds and large institutions have $40.1M invested in Filana Therapeutics in 2025 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 33 reducing their positions, and 13 closing their positions.
183% more call options, than puts
Call options by funds: $4.73M | Put options by funds: $1.67M
81% more capital invested
Capital invested by funds: $22.1M → $40.1M (+$17.9M)
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
6% more funds holding
Funds holding: 97 → 103 (+6)
3.19% more ownership
Funds ownership: 25.33% → 28.52% (+3.2%)
39% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$4.58M |
| 2 |
6CM
683 Capital Management
New York
|
+$977K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$517K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$332K |
| 5 |
VCM
Voleon Capital Management
Berkeley,
California
|
+$327K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Charles Schwab
San Francisco,
California
|
-$550K |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$535K |
| 3 |
JP Morgan Chase
New York
|
-$441K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$367K |
| 5 |
Millennium Management
New York
|
-$354K |
FLNA Hedge Fund Activity: Q3 2025 in Review
103 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2025, worth a combined $40.1M — up 81% from $22.1M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new FLNA positions and 13 closed out — a net gain of 7 holders — while 20 added to existing stakes and 33 trimmed.
The largest buyer was Marshall Wace, adding an estimated $4.58M. The largest seller was Charles Schwab, cutting an estimated $550K.
- 103 institutional investors held Filana Therapeutics (FLNA) as of Q3 2025, up from 97 in Q2 2025.
- Funds reported $40.1M of Filana Therapeutics stock for Q3 2025, up 81% quarter-over-quarter.
- 20 funds opened new Filana Therapeutics positions in Q3 2025 and 13 closed out, a net change of +7 holders.
- The largest Filana Therapeutics buyer in Q3 2025 was Marshall Wace, an estimated $4.58M added.
- The largest Filana Therapeutics seller in Q3 2025 was Charles Schwab, an estimated $550K sold.
Based on aggregated 13F filings for Q3 2025.